Literature DB >> 3314882

Detection of murine S180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody.

M Volm1, T Efferth, A Günther, B Lathan.   

Abstract

Doxorubicin (adriamycin) preconditioned S180 cells were more resistant to doxorubicin. The resistance was detected by three different methods (short-term test, colony assay, tissue culture assay). The doxorubicin-resistant S180 cells express the pleitrop drug resistance phenotype. There exists a multidrug resistance to doxorubicin, dactinomycin (actinomycin D), vincristine and colchicine. In addition, collateral sensitivity was found to fluorouracil (5-fluorouracil) and methotrexate. This multidrug phenotype is in accordance with the pleiotropic phenotype of colchicine-resistant CHO cells. Resistant S180 cells express a glycoprotein of Mr 170 kd determined by indirect immunofluorescence using a monoclonal antibody (Mab 265/F4) to the P-glycoprotein of colchicine-resistant CHO-cells. The P-glycoprotein could be an important prognostic factors for tumors with multidrug resistance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3314882

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

1.  Correlations between natural resistance to doxorubicin, proliferative activity, and expression of P-glycoprotein 170 in human kidney tumor cell lines.

Authors:  T Efferth; H Löhrke; M Volm
Journal:  Urol Res       Date:  1990

2.  Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein.

Authors:  M Volm; M Bak; T Efferth; J Mattern
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 3.  Antibody-directed therapy of multidrug-resistant tumor cells.

Authors:  T Efferth; M Volm
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

4.  P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake.

Authors:  D de Graaf; R C Sharma; E B Mechetner; R T Schimke; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  P-glycoprotein expression in treated and untreated human breast cancer.

Authors:  J Schneider; M Bak; T Efferth; M Kaufmann; J Mattern; M Volm
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

6.  Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4.

Authors:  T Efferth; B Lathan; M Volm
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

7.  Protein expression profiles indicative for drug resistance of non-small cell lung cancer.

Authors:  M Volm; R Koomägi; J Mattern; T Efferth
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.